Found: 4
Select item for more details and to access through your institution.
TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1661, doi. 10.3390/ijms19061661
- By:
- Publication type:
- Article
Usage of the NF-κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 4, p. 469
- By:
- Publication type:
- Article
NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41419-022-05535-9
- By:
- Publication type:
- Article
The HSF1-CPT1a Pathway Is Differentially Regulated in NAFLD Progression.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3504, doi. 10.3390/cells11213504
- By:
- Publication type:
- Article